Analysis of 60 Patients with Relapsed or Refractory T-Cell Acute Lymphoblastic Leukemia and T-Cell Lymphoblastic Lymphoma Treated with CD7-Targeted Chimeric Antigen Receptor-T Cell Therapy

By
Jamie Kang
-
0
118
In this Phase I/II clinical trial, 65 pediatric and adult patients with refractory/relapsed T cell acute lymphoblastic leukemia and lymphoblastic lymphoma were enrolled.
[American Journal Of Hematology]
Abstract